LOGIN  |  REGISTER

Recent Insider Transactions - KalVista Pharmaceuticals (NASDAQ: KALV)

Follow NASDAQ:KALV Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ KALV KalVista Pharmaceuticals
Audhya Paul K. / officer: CHIEF MEDICAL OFFICER
05/23/2025
Sell
$11.31
2,146
$24K
113,026
NASDAQ KALV KalVista Pharmaceuticals
Yea Christopher / officer: CHIEF DEVELOPMENT OFFICER
05/23/2025
Sell
$11.31
1,926
$22K
98,189
NASDAQ KALV KalVista Pharmaceuticals
Audhya Paul K. / officer: CHIEF MEDICAL OFFICER
05/22/2025
Sell
$11.88
2,689
$32K
110,172
NASDAQ KALV KalVista Pharmaceuticals
Yea Christopher / officer: CHIEF DEVELOPMENT OFFICER
05/22/2025
Sell
$11.88
2,317
$28K
96,990
NASDAQ KALV KalVista Pharmaceuticals
Palleiko Benjamin L / director, officer: CHIEF EXECUTIVE OFFICER
05/22/2025
Sell
$11.88
9,999
$119K
306,618
NASDAQ KALV KalVista Pharmaceuticals
Yea Christopher / officer: CHIEF DEVELOPMENT OFFICER
05/19/2025
Sell
$11.84
2,600
$31K
95,557
NASDAQ KALV KalVista Pharmaceuticals
Palleiko Benjamin L / director, officer: CHIEF EXECUTIVE OFFICER
05/19/2025
Sell
$11.84
3,808
$45K
293,367
NASDAQ KALV KalVista Pharmaceuticals
Audhya Paul K. / officer: CHIEF MEDICAL OFFICER
05/19/2025
Sell
$11.84
2,776
$33K
106,611
NASDAQ KALV KalVista Pharmaceuticals
Venrock Healthcare Capital Partners III, L.P. / 10 percent owner
04/09/2025
Buy
$9.42
25,000
$236K
5.30M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous